Cardiovascular risk after total thyroidectomy in patients with differentiated thyroid carcinoma undergoing levothyroxine replacement monotherapy
These findings highlight the need for careful cardiovascular monitoring during long-term follow-up in patients with differentiated thyroid cancer. Specific cardiovascular management guidelines are needed in DTC, similar to those available for other cancer populations, to balance the risks and benefits of LT4 therapy and to identify patients at higher cardiovascular risk who may need closer monitoring.
Authors
- Maria Carola Gifuni
- F. Ghezzi (ORCID: https://orcid.org/0000-0003-3363-5187)
- Marco Iannotta
- Franco De Crescenzo (ORCID: https://orcid.org/0000-0002-2478-7763)
- Roberta Esposito (ORCID: https://orcid.org/0000-0002-0051-7152)
- Martina Pucci
- Bernadette Biondi (ORCID: https://orcid.org/0000-0001-8360-4464)
- Stefania Ruberto
- Marilena Calzolaio
Institutions
- Federico II University Hospital (IT)
- University of Naples Federico II (IT)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-08-26
- DOI
- https://doi.org/10.3389/fendo.2025.1659736
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00